Riluzole and amyotrophic lateral sclerosis survival | 合法藥品大搜索

2013年3月31日 — 關鍵字：脊髓側索硬化症、ALS、riluzole、amyotrophic lateral sclerosis (ALS). 壹、前言. 1. 脊髓側索硬化症(amyotrophic lateral sclerosis, ALS) ... Read More

Rilutek (riluzole) was the first treatment approved by the U.S. Food and Drug Administration (FDA) to treat amyotrophic lateral sclerosis (ALS). Rilutek is an oral ... Read More

由 T Dharmadasa 著作 · 2018 · 被引用 48 次 — Dose-ranging study of riluzole in amyotrophic lateral sclerosis. ... Fang and colleagues showed that 100 mg/day of riluzole was associated with ... Read More

由 RG Miller 著作 · 2002 · 被引用 1381 次 — Riluzole 100 mg daily is reasonably safe and probably prolongs survival by about two months in patients with amyotrophic lateral sclerosis. More studies are​ ... Read More

由 S Zoccolella 著作 · 2007 · 被引用 125 次 — Riluzole is to date the only treatment that prolongs amyotrophic lateral sclerosis (​ALS) survival. However, results on the efficacy of riluzole in observational ... Read More

由 T Fang 著作 · 2018 · 被引用 104 次 — Riluzole, a glutamatergic antagonist, is the only disease-modifying treatment shown to extend life in patients with ALS, associated with a 38·6% reduction in ... Read More

Efficacy of riluzole for the treatment of ALS: real-world ... · 由 M Hinchcliffe 著作 · 2017 · 被引用 35 次 — Riluzole is indicated for the treatment of patients with amyotrophic lateral sclerosis ( ... Read More

2019年11月25日 — 至今FDA已經核准Rilutek、Tiglutik和Radicava（edaravone）這三款藥物來治療ALS。其中Riluzole（Rilutek）是最早獲准的ALS治療藥物，於 ... Read More

對漸凍人的治療建議，目前核准使用於治療ALS 藥物還是以Riluzole（Rilutek）為主，這個藥物是一種麩氨酸拮抗藥物，麩氨酸本身是一種興奮性胺基酸，被認為與 ... Read More